Effect of tocilizumab, sarilumab, and baricitinib on mortality among patients hospitalized for COVID-19 treated with corticosteroids: a systematic review and meta-analysis

por Albuquerque, Arthur M., Eckert, Igor, Tramujas, Lucas, Butler-Laporte, Guillaume, McDonald, Emily G., Brophy, James M., Lee, Todd C.
Publicado 2023

Sars-Cov-2 exposures of healthcare workers and acquisition of COVID-19

por Leal, Jenine, Jefferson, Tom, Conly, John
Publicado 2022

Pre-exposure prophylaxis with tixagevimab and cilgavimab (Evusheld) for COVID-19 among 1112 severely immunocompromised patients

por Nguyen, Yann, Flahault, Adrien, Chavarot, Nathalie, Melenotte, Cléa, Cheminant, Morgane, Deschamps, Paul, Carlier, Nicolas, Lafont, Emmanuel, Thomas, Marion, Flamarion, Edouard, Lebeaux, David, Charlier, Caroline, Rachline, Anne, Guérin, Corinne, Ratiney, Robert, Touchard, Justine, Péré, Hélène, Rozenberg, Flore, Lanternier, Fanny, Arlet, Jean-Benoît, Avouac, Jérôme, Boussaud, Véronique, Guillemain, Romain, Vignon, Marguerite, Thervet, Eric, Scemla, Anne, Weiss, Laurence, Mouthon, Luc
Publicado 2022

Effectiveness of MRNA booster vaccine among healthcare workers in New York City during the Omicron surge, December 2021 to January 2022

por Robilotti, Elizabeth V., Whiting, Karissa, Lucca, Anabella, Poon, Chester, Jani, Krupa, McMillen, Tracy, Freeswick, Scott, Korenstein, Deborah, Babady, N. Esther, Seshan, Venkatraman E., Kamboj, Mini
Publicado 2022

Trend in industry payments to infectious disease physicians in the United States: a seven-year analysis of nonresearch payments from the Open Payments Database between 2014 and 202...

por Murayama, Anju, Nakano, Kenji, Kamamoto, Sae, Sato, Masaya, Saito, Hiroaki, Tanimoto, Tetsuya, Ozaki, Akihiko
Publicado 2022

Daily tenofovir disoproxil fumarate/emtricitabine and hydroxychloroquine for pre-exposure prophylaxis of COVID-19: a double-blind placebo-controlled randomized trial in healthcare...

por Polo, Rosa, García-Albéniz, Xabier, Terán, Carolina, Morales, Miguel, Rial-Crestelo, David, Garcinuño, M. Angeles, García del Toro, Miguel, Hita, César, Gómez-Sirvent, Juan Luis, Buzón, Luis, Díaz de Santiago, Alberto, Arellano, Jose Pérez, Sanz, Jesus, Bachiller, Pablo, Alfaro, Elisa Martínez, Díaz-Brito, Vicente, Masiá, Mar, Hernández-Torres, Alicia, Guerra, Jose M., Santos, Jesús, Arazo, Piedad, Muñoz, Leopoldo, Arribas, Jose Ramon, Martínez de Salazar, Pablo, Moreno, Santiago, Hernán, Miguel A., Del Amo, Julia
Publicado 2023

Perpetual observational studies: new strategies to support efficient implementation of observational studies and randomized trials in infectious diseases

por Hassoun-Kheir, Nasreen, van Werkhoven, C. Henri, Dunning, Jake, Jaenisch, Thomas, van Beek, Janko, Bielicki, Julia, Butler, Christopher C., Francois, Bruno, Harbarth, Stephan, Hernandez Padilla, Ana C., Horby, Peter, Koopmans, Marion, Lee, James, Rodriguez-Baño, Jesús, Tacconelli, Evelina, Themistocleous, Yrene, van der Velden, Alike W., Bonten, Marc, Goossens, Herman, de Kraker, Marlieke E.A.
Publicado 2022

Re: ‘Association between IgG antibody levels and adverse events after first and second BNT162b2 mRNA vaccine doses’ by Braun et al

por Zhou, Yuchi, Liu, Xiangting, Wang, Xia, Li, Hui, Zeng, Guangting
Publicado 2022

Blockbuster effect of COVID-19 on the impact factor of infectious disease journals

por Maillard, Alexis, Delory, Tristan
Publicado 2022

Vaccine effectiveness against Delta, Omicron BA.1, and BA.2 in a highly vaccinated Asian setting: a test-negative design study

por Tan, Celine Y., Chiew, Calvin J., Pang, Deanette, Lee, Vernon J., Ong, Benjamin, Lye, David Chien, Tan, Kelvin Bryan
Publicado 2023

Virus variant–specific clinical performance of SARS coronavirus two rapid antigen tests in point-of-care use, from November 2020 to January 2022

por Wagenhäuser, Isabell, Knies, Kerstin, Hofmann, Daniela, Rauschenberger, Vera, Eisenmann, Michael, Reusch, Julia, Gabel, Alexander, Flemming, Sven, Andres, Oliver, Petri, Nils, Topp, Max S., Papsdorf, Michael, McDonogh, Miriam, Verma-Führing, Raoul, Scherzad, Agmal, Zeller, Daniel, Böhm, Hartmut, Gesierich, Anja, Seitz, Anna K., Kiderlen, Michael, Gawlik, Micha, Taurines, Regina, Wurmb, Thomas, Ernestus, Ralf-Ingo, Forster, Johannes, Weismann, Dirk, Weißbrich, Benedikt, Dölken, Lars, Liese, Johannes, Kaderali, Lars, Kurzai, Oliver, Vogel, Ulrich, Krone, Manuel
Publicado 2023

European society of clinical microbiology and infectious diseases guidelines for coronavirus disease 2019: an update on treatment of patients with mild/moderate disease

por Bartoletti, Michele, Azap, Ozlem, Barac, Aleksandra, Bussini, Linda, Ergonul, Onder, Krause, Robert, Martin-Quiros, Alejandro, Paño-Pardo, José Ramón, Power, Nicholas, Sibani, Marcella, Szabo, Balint Gergely, Tsiodras, Sotirios, Zollner-Schwetz, Ines, Rodríguez-Baño, Jesús
Publicado 2022

Assessing the impact of coronavirus disease 2019 on mortality: a population-based, matched case-control study

por Turjeman, Adi, Wirtheim, Eytan, Poran, Itamar, Leibovici, Leonard
Publicado 2023

Effectiveness of first-generation severe acute respiratory syndrome coronavirus 2 mRNA vaccines against the Omicron variant

por Dagan, Noa, Barda, Noam
Publicado 2022

The disease burden of Delta and Omicron variants of severe acute respiratory syndrome coronavirus 2 in a predominantly vaccinated and healthy cohort

por Sendi, Parham, Branca, Mattia, Büchi, Annina Elisabeth, Widmer, Nadja, Tande, Aaron J., Gowland, Peter
Publicado 2022

Prospective population-level validation of the Abbott ID NOW severe acute respiratory syndrome coronavirus 2 device implemented in multiple settings for testing asymptomatic and sy...

por Stokes, William, Venner, Allison A., Buss, Emily, Tipples, Graham, Berenger, Byron M.
Publicado 2023

Evaluating the efficacy and safety of SpikoGen®, an Advax-CpG55.2–adjuvanted severe acute respiratory syndrome coronavirus 2 spike protein vaccine: a phase 3 randomized placebo-con...

por Tabarsi, Payam, Anjidani, Nassim, Shahpari, Ramin, Mardani, Masoud, Sabzvari, Araz, Yazdani, Babak, Kafi, Hamidreza, Fallah, Newsha, Ebrahimi, Ali, Taheri, Ali, Petrovsky, Nikolai, Barati, Saghar
Publicado 2023

RNA loads of severe acute respiratory syndrome coronavirus 2 in patients with breakthrough coronavirus disease 2019 caused by the Delta and Omicron variants

por de Michelena, Paula, Torres, Ignacio, Ferrando, Enric-Cuevas, Olea, Beatriz, González-Candelas, Fernando, Sánchez, Gloria, Navarro, David
Publicado 2023

Association between a low response to rubella vaccination and reduced anti-severe acute respiratory syndrome coronavirus 2 immune response after vaccination with BNT162b2: a cross-...

por Nakaharai, Kazuhiko, Nakazawa, Yasushi, Mishima, Yukie, Saito, Mari, Shinozaki, Yoichi, Yoshida, Masaki
Publicado 2023

Previous omicron infection may be protective against reinfection with omicron variant BA.5 for at least 5 months

por Koga, Michiko, Iwatsuki-Horimoto, Kiyoko, Kikuchi, Tetsuhiro, Yamayoshi, Seiya, Kawaoka, Yoshihiro, Yotsuyanagi, Hiroshi
Publicado 2023